Akina key facts
as of Oct 2026- Developer of artificial intelligence healthcare software designed to embrace movement's full potential through AI-enhanced physiotherapy.
- Akina is valued at approximately $11.1M as of Oct 2026 (last reported valuation).
- It has raised $4.9M; the latest was Accelerator/Incubator in May 2025.
- Notable investors include Venture Kick, Innosuisse, Kickfund, Freigeist, AI Startup Center — 8 tracked in total.
- Status: Privately Held (backing).
Akina's last reported valuation, Jan 2025. Nothing priced has surfaced since.
- ·Watch Akina: the Monday email on marks, rounds and moves
Akina funding rounds
No funding rounds for Akina are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Akina valuation
Akina's last reported valuation was $11.1 million in Jan 2025. No priced round, secondary trade or fund mark has surfaced since.
Akina investors
8 investors are on record for Akina, including Venture Kick, Innosuisse, Kickfund and Freigeist.
About Akina
Developer of artificial intelligence healthcare software designed to embrace movement's full potential through AI-enhanced physiotherapy. The company offers services that empower patients during independent physiotherapy at home and connect them to healthcare providers for remote therapeutic monitoring, personalized guidance through proprietary AI motion analysis and media streaming algorithms, and automated case review and feedback generation for therapists, enabling patients to ensure the efficiency of care delivery and improving clinical outcomes.
- Sector
- Healthcare
- HQ
- Zürich, Switzerland
- Founded
- 2021
- Employees
- 20
- Website
- akina.health/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.